Software solution"Support" with essex pharma
Hepatitis C counts among the accompanying illnesses in i.v. opiate addicts, which are particularly difficult to treat. Only recently have regulations been established recommending a therapy of this illness that often accompanies drug addiction. In order to assure the quality of this treatment, we were supposed to develop a software solution designed to support and document the entire therapy process./>
In order to make the therapy of drug users more effective, the treatment demands an intense medical attendance, with the patients having to see the doctor in regular intervals. Our software solution SUPPORT (treatment of substitution patients with PegIntron and Rebetol) was expected to back up all details of the therapy. The programme was supposed to support the therapy by structuring the complex treatment process and documenting the results.
After the successful completion of the development phase, we started to implement and use SUPPORT in October 2005. 600 patients suffering from an infection with chronic hepatitis C have been treated in 60 treatment sites. The project was initially designed as a study.
Partner in this Project